Thursday, March 20, 2025 2:56:54 PM
The company has acquired ABBIE patents and its technology from CGA369 Intellectual Holdings, Inc. and have made
partial payment as per agreement. However, due to some avoidable circumstances, the remaining payments and issuance
of stocks are pending, and the company has successfully negotiated and extended terms with CGA360 Intellectual
Holding, Inc.
https://www.otcmarkets.com/otcapi/company/financial-report/416156/content
imo " avoidable " was a mistake, should be " unavoidable "...that's my guess, you can ask them, I know you love to e-mail IR....
Bullish
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
